| Code | 4521A | ||||||||||
| MA number | 16/0086/13-S | ||||||||||
| Product Form: | tbl ent 60x100 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 22.03.2013 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Vasopirin_03.2021.pdf
|
| PIL: |
PIL_Vasopirin_03.2021.pdf
|
| Safety feature | No |
| Data update: | 08.06.2020 |
